Northern Trust Corp Intra Cellular Therapies, Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 491,931 shares of ITCI stock, worth $42.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
491,931
Previous 897,954 45.22%
Holding current value
$42.1 Million
Previous $61.5 Million 41.51%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$67.99 - $80.84 $27.6 Million - $32.8 Million
-406,023 Reduced 45.22%
491,931 $36 Million
Q2 2024

Aug 14, 2024
BUY
$64.76 - $79.84 $1.29 Million - $1.59 Million
19,962 Added 2.27%
897,954 $61.5 Million
Q1 2024

May 14, 2024
SELL
$64.37 - $75.65 $2.98 Million - $3.5 Million
-46,223 Reduced 5.0%
877,992 $60.8 Million
Q4 2023

Feb 13, 2024
SELL
$46.37 - $73.65 $1.14 Million - $1.81 Million
-24,583 Reduced 2.59%
924,215 $66.2 Million
Q3 2023

Nov 13, 2023
BUY
$52.09 - $64.1 $589,137 - $724,970
11,310 Added 1.21%
948,798 $49.4 Million
Q2 2023

Aug 11, 2023
BUY
$54.67 - $66.44 $1.09 Million - $1.33 Million
20,010 Added 2.18%
937,488 $59.4 Million
Q1 2023

May 15, 2023
SELL
$43.8 - $56.99 $713,195 - $927,968
-16,283 Reduced 1.74%
917,478 $49.7 Million
Q4 2022

Feb 13, 2023
BUY
$44.07 - $54.45 $110,086 - $136,016
2,498 Added 0.27%
933,761 $49.4 Million
Q3 2022

Nov 14, 2022
SELL
$42.7 - $59.99 $183,994 - $258,496
-4,309 Reduced 0.46%
931,263 $43.3 Million
Q2 2022

Aug 12, 2022
BUY
$43.0 - $65.64 $2.65 Million - $4.04 Million
61,594 Added 7.05%
935,572 $53.4 Million
Q1 2022

May 13, 2022
BUY
$38.74 - $62.09 $2.38 Million - $3.81 Million
61,392 Added 7.56%
873,978 $53.5 Million
Q4 2021

Feb 08, 2022
SELL
$35.2 - $53.42 $570,627 - $865,991
-16,211 Reduced 1.96%
812,586 $42.5 Million
Q3 2021

Nov 15, 2021
SELL
$28.72 - $42.49 $828,945 - $1.23 Million
-28,863 Reduced 3.37%
828,797 $30.9 Million
Q2 2021

Aug 13, 2021
BUY
$29.3 - $44.5 $964,321 - $1.46 Million
32,912 Added 3.99%
857,660 $35 Million
Q1 2021

May 12, 2021
SELL
$30.8 - $39.51 $4 Million - $5.13 Million
-129,803 Reduced 13.6%
824,748 $28 Million
Q4 2020

Feb 11, 2021
SELL
$23.34 - $32.22 $374,933 - $517,582
-16,064 Reduced 1.66%
954,551 $30.4 Million
Q3 2020

Nov 16, 2020
BUY
$17.61 - $31.86 $1.48 Million - $2.68 Million
84,097 Added 9.49%
970,615 $24.9 Million
Q2 2020

Aug 14, 2020
BUY
$14.35 - $26.64 $3 Million - $5.57 Million
209,045 Added 30.86%
886,518 $22.8 Million
Q1 2020

May 14, 2020
BUY
$12.31 - $33.12 $1.32 Million - $3.55 Million
107,125 Added 18.78%
677,473 $10.4 Million
Q4 2019

Feb 14, 2020
SELL
$7.26 - $38.49 $129,438 - $686,238
-17,829 Reduced 3.03%
570,348 $19.6 Million
Q3 2019

Nov 13, 2019
BUY
$7.47 - $14.03 $205,992 - $386,891
27,576 Added 4.92%
588,177 $4.39 Million
Q2 2019

Aug 13, 2019
BUY
$10.65 - $14.29 $91,206 - $122,379
8,564 Added 1.55%
560,601 $7.28 Million
Q1 2019

May 13, 2019
BUY
$10.9 - $14.09 $38,477 - $49,737
3,530 Added 0.64%
552,037 $6.73 Million
Q4 2018

Feb 12, 2019
SELL
$10.36 - $20.96 $55,653 - $112,597
-5,372 Reduced 0.97%
548,507 $6.25 Million
Q3 2018

Nov 14, 2018
BUY
$17.77 - $22.9 $246,345 - $317,462
13,863 Added 2.57%
553,879 $12 Million
Q2 2018

Sep 18, 2018
SELL
$17.33 - $23.4 $61,885 - $83,561
-3,571 Reduced 0.66%
540,016 $9.54 Million
Q2 2018

Aug 14, 2018
BUY
$17.33 - $23.4 $866,915 - $1.17 Million
50,024 Added 10.14%
543,587 $9.61 Million
Q1 2018

May 09, 2018
BUY
$15.16 - $25.49 $115,185 - $193,673
7,598 Added 1.56%
493,563 $10.4 Million
Q4 2017

Feb 14, 2018
BUY
$14.27 - $16.79 $1.17 Million - $1.38 Million
82,140 Added 20.34%
485,965 $7.04 Million
Q3 2017

Nov 13, 2017
BUY
$10.77 - $22.1 $4.35 Million - $8.92 Million
403,825
403,825 $6.37 Million

Others Institutions Holding ITCI

# of Institutions
377
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.08B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email